2015 Comprehensive Anti-Doping Protocols
Anti-Doping protocols for the 2015 Amgen Tour of California have been announced by AEG, owners and presenters of the race. With the cooperation and encouragement of the participating teams and riders and as part of the strict and comprehensive programs previously established, Pre-Race Anti-Doping criteria testing will be administered by the US Anti- Doping Agency (USADA) while In-Competition testing will be conducted by USADA, in collaboration with the Union Cycliste Internationale (UCI). For the first time, USADA will also conduct In-Competition testing on the women's race as part of the USA Cycling RaceClean(tm) program. All programs will be administered in accordance with the World Anti-Doping Code (Code)
The 2015 program for riders will include the following components:
Pre- Race Testing and Protocols:
- USADA will conduct no-advance notice, out-of-competition sample collections during the period of time leading up to the start of the race on riders under USADA's jurisdiction
- All riders will be subject to urine and/or blood testing
- Samples will be tested for the substances and methods included on the World Anti-Doping Agency (WADA) Prohibited List, such as steroids, hormones (e.g. EPO), stimulants and various masking agents and could be subject to special analysis such as CIR and testing for CERA and hGH. For a full list of the substances and methods listed on the WADA Prohibited List please visit, www.usada.org/prohibited-list/
- All participants must be in a registered testing pool leading up to the race and provide up-to-date whereabouts information so they may be located for testing at any location and at any time, without advance notice
- Athletes who are not already in a registered testing pool will be required to take mandatory educational programming, which includes comprehensive information on the anti-doping rules and athlete rights and responsibilities, as well as information on the merits and benefits of clean competition
- Additional education programming opportunities will be made accessible to all riders, teams and support personnel during the 90-day race lead-up to ensure maximum understanding of the specific anti-doping rules
In-Competition Testing and Protocols:
Testing will be conducted throughout the Amgen Tour of California by USADA, in collaboration with the Union Cycliste Internationale (UCI) and in accordance with the World Anti-Doping Code . This will include daily doping controls following a strategic test distribution plan. Samples may be tested for the substances and methods included on the WADA Prohibited List, including EPO.
AEG has additionally requested and will pay for EPO testing on all samples collected as part of the in-competition testing program. For a full list of the substances and methods listed on the WADA Prohibited List please visit, www.usada.org/prohibited-list/. After each stage, testing will include but will not be limited to the following riders:
- The winner of each stage
- The leader in the General Classification
- At least two athletes randomly selected
- Additional riders may be subject to blood or urine testing
About the US Anti-Doping Agency
USADA is the non-profit, independent and non-governmental organization responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline as well as the Global Drug Reference Online at www.GlobalDRO.org, conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curriculums, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org.
About the USA Cycling RaceClean(tm) Program
USA Cycling created the RaceClean program as part of its ongoing commitment to clean sport, ensuring a level playing field, and promoting athletes' health and well-being. This will be accomplished through a dual approach of increased education, using the resources developed by the U.S. Anti-Doping Agency (USADA), the World Anti-Doping Agency (WADA), and the Union Cycliste Internationale (UCI), and increasing the frequency and effectiveness of in-competition and out-of-competition drug testing at all levels of competitive cycling in the United States that is governed by USA Cycling. The goal of the RaceClean program is to eradicate the use of performance enhancing drugs and techniques in cycling. Learn more at https://www.usacycling.org/usa-cycling-raceclean-program.htm.
About the UCI
The International Cycling Union (UCI) is cycling's International Federation recognised by the International Olympic Committee (IOC). The UCI was founded in Paris in 1900. The UCI administers and promotes the development of the eight disciplines of cycling all around the world (road, track, mountain bike, BMX, para-cycling, cyclo-cross, trials and indoor cycling). Over the last 10 years, the UCI has intensified its development activities on all five continents. The UCI's mission is to develop and promote cycling, in close collaboration with National Federations, be it as a competition sport and its associated values (effort, well-being and fair play), as a healthy recreational activity or as a means of transport. Please see attached a link that provides information regarding UCI's, "fight against doping". http://www.uci.ch/templates/UCI/UCI2/layout.asp?MenuId=MTk3OA&LangId=1